NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.950
-0.430 (-18.07%)
At close: Dec 20, 2024, 4:00 PM
1.900
-0.050 (-2.56%)
After-hours: Dec 20, 2024, 7:59 PM EST
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $3.16 million as of December 20, 2024. Its market cap has decreased by -79.03% in one year.
Market Cap
3.16M
Enterprise Value
4.32M
1-Year Change
-79.03%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $3.16M, a decrease of -84.27%. That is a compound annual growth rate of -37.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.16M | -83.46% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 3.23M |
| GlucoTrack | 3.18M |
| Theriva Biologics | 3.17M |
| Psyence Biomedical | 3.17M |
| Azitra | 3.16M |
| InMed Pharmaceuticals | 3.16M |
| Lipella Pharmaceuticals | 3.16M |
| Alaunos Therapeutics | 3.14M |